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Abstract
Linear IgA bullous dermatosis (LABD) is a rare blistering skin
disease characterized by basement membrane zone deposition
of IgA. This study identifies a tissue antigen detected by pa-
tient serum and then isolates the autoantibody using epidermis
and protein bands blotted on nitrocellulose as immunoab-
sorbents.
Sera from 10 patients (9 with cutaneous disease and 1 with
cicatrizing conjunctivitis) were evaluated. Indirect immunoflu-
orescence revealed an IgA anti-basement membrane antibody
in 6 of 10 sera with monkey esophagus substrate and 9 of 10
sera with human epidermal substrate. Immunoblotting was
performed on epidermal and dermal extracts prepared from
skin separated at the basement membrane zone with either
sodium chloride or EDTA. Saline-separated skin expressed a
97-kD band in dermal extract alone that was recognized by 4 of
10 sera. EDTA-separated skin expressed the 97-kD band in
both epidermal (4 of 10 sera) and dermal (6 of 10 sera) extract.
Immunoabsorption of positive sera with epidermis purified an
IgA antibody that reacted uniquely with the 97-kD band. In
addition, IgA antibody bound to nitrocellulose was eluted from
the 97-kD band and found to uniquely bind basement mem-
brane zone.
It is likely that the 97-kD protein identified by these tech-
niques is responsible for basement membrane binding of IgA in
LABD. (J. Clin. Invest. 1990. 85:812-820.) IgA * dermatitis
herpetiformis - linear IgA bullous dermatosis * basement
membrane zone
Introduction
Linear IgA bullous dermatosis (LABD)l is a rare acquired
subepidermal blistering disease of the skin which has been
defined on the basis of its unique immunopathologic finding
of linear IgA along the cutaneous basement membrane (1).
LABD was initially considered to be a variant of dermatitis
herpetiformis (2). However, LABD has been separated from
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classical dermatitis herpetiformis that demonstrates granular
deposition of IgA in dermal papillary tips. Patients with der-
matitis herpetiformis also have a high frequency of the HLA
B8 DR3 haplotype, and gluten-sensitive enteropathy, which is
not present in LABDpatients (3, 4). Somepatients with LABD
demonstrate a circulating IgA-class anti-basement membrane
antibody on indirect immunofluorescence, whereas sera from
patients with dermatitis herpetiformis have not demonstrated
a circulating antibody that binds to skin (2). Immunoelectron
microscopy in LABDreveals two patterns of IgA deposition.
One group has immunoglobulin deposition in the sublamina
densa, whereas the second group shows deposition of immu-
noglobulin in the lamina lucida (5-8).
LABD can also be contrasted with other subepidermal
blistering diseases of the skin on the basis of immunopathol-
ogy. Both epidermolysis bullosa acquisita and bullous pem-
phigoid demonstrate the deposition of IgG-class antibody
along the basement membrane on direct immunofluorescence
and frequently a circulating IgG-class anti-basement mem-
brane antibody. The epidermolysis bullosa acquisita antigen
has been identified as a 290-kD protein that is type VII colla-
gen and is present in the sub-basal lamina (9, 10). The major
bullous pemphigoid antigen has been identified as a 240-kD
epidermal protein present in the lamina lucida (1 1, 12). Be-
cause some patients with LABDhave deposition of IgA in the
lamina lucida, LABD has been referred to as "IgA pemphi-
goid" by some, implying that it is simply an IgA-class immune
response to the bullous pemphigoid antigen (7).
Wepresent evidence here that sera from patients with lin-
ear IgA disease contain an IgA-class antibody that selectively
binds a 97-kD protein extracted from both normal human
epidermis and dermis. This antigen differs from the major
bullous pemphigoid antigen and the epidermolysis bullosa ac-
quisita antigen on the basis of molecular weight and tissue
distribution. Moreover, we show that this antibody can be
isolated using both the human basement membrane zone and
nitrocellulose as an immunoabsorbent. Antibody isolated by
these techniques reacts uniquely with basement membrane
and the 97-kD protein.
Methods
Patient sera. Sera from 10 patients with linear IgA disease (age range
28-51 yr) seen over a 10-yr period were evaluated. Nine patients had
lesions limited to the skin with sparing of mucous membranes and
demonstrated linear deposition of IgA along the basement membrane
when perilesional, clinically normal-appearing skin was biopsied.
Serum from one patient with cicatrizing conjunctivitis and no cutane-
ous lesions was also evaluated. This patient demonstrated only IgA
basement membrane deposition on conjunctival biopsy. Patients with
both IgG and IgA deposition along the basement membrane were
excluded. The serum from a bullous pemphigoid patient with an anti-
basement membrane antibody titer 1:10,240 on monkey esophagus
was used as a control for Western blots of epidermal extract. Serum
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from a patient with epidermolysis bullosa acquisita with an anti-base-
ment membrane antibody titer of 1:1,280 on monkey esophagus
served as a control for Western blots of dermal extracts. Sera from
laboratory personnel were used as normal controls.
Indirect immunofluorescence. Indirect immunofluorescence was
performed on monkey esophagus sections (Immunofluorescent Test-
ing Service, Buffalo, NY), and saline-split normal human skin. Normal
human skin was obtained from cadavers, keratomed to a thickness of
0.5 mm, washed in PBS(0.126 MNaCl, 0.008 MNa2HPO4, and 0.002
MKH2PO4pH 7.2), frozen at -70'C, thawed, then incubated in I M
NaCl with 10 AMPMSFfor 18 h at 4VC. The epidermis and dermis
were then separated, washed in PBS, imbedded in OCTcompound
(Miles Scientific Div., Naperville, IL), and stored at -70'C. Within 1
mo, 6-um sections were cut on a cryostat microtome. Test sera were
then progressively diluted and applied to monkey esophagus and sa-
line-split dermis and epidermis, incubated for 30 min at 250C, washed
with PBS, and then stained with fluorescein-conjugated anti-IgG di-
luted 1:60 in PBS (Cappel Laboratories, Malvern, PA), gammachain-
specific, total protein 31.7 mg/ml, antibody concentration 5.0 mg/ml,
fluorescein/protein ratio 4:1, or anti-IgA diluted 1:80 in PBS (Cappel
Laboratories), alpha chain-specific, total protein 18.6 mg/ml, antibody
concentration 6.0 mg/ml, and fluorescein/protein ratio 3:0, for 30
min, and finally washed with PBS. The limiting titer of anti-basement
membrane antibody was then determined by epifluorescent micros-
copy.
Immunoelectron microscopy. Immunoelectron microscopy was
performed on patients 2 and 3 (Table I) by Dr. Robert A. Briggaman at
the University of North Carolina, Chapel Hill, NC. Both specimens
revealed deposition of IgA within the lamina lucida.
Preparation of epidermal and dermal extracts. Normal human skin
was separated from the dermis at the basement membrane zone by two
methods: (a) 1 Msodium chloride as described above; (b) alternatively,
20 mMEDTA, 10 MMPMSFin PBSwas substituted for I Msodium
chloride in the identical procedure noted above. Epidermal proteins
were immediately extracted with 1% SDSand 5% beta-mercaptoeth-
anol in 25 mMTris buffer (pH 7.8) with 10MgMPMSFby the method
of Labib (13). Dermal proteins were extracted with 8 Murea and 0.3 M
beta-mercaptoethanol in 25 mMTris buffer (pH 7.8) with 10 uM
PMSFfor I h as described by Scaletta (14). The extract was then
dialyzed extensively against distilled water at 4°C and then Iyophilized.
SDS-PAGEwas performed as outlined by Laemmli (15) in 6.5% (epi-
dermal extract) and 8%(dermal extract) polyacrylamide. Proteins from
nonstained gels were transferred electrophoretically onto nitrocellulose
sheets (Western blots) as described by Towbin (16). LABD sera and
normal human sera were diluted 1:10, epidermolysis bullosa acquisita
serum was diluted 1:200, and bullous pemphigoid serum 1:1 00 in PBS
with 0.5% BSA and 0.05% Tween 20 (ATPBS). Diluted sera were
incubated with sectioned nitrocellulose sheets and developed using
biotin-labeled second antibody and an avidin-biotin-peroxidase com-
plex as described previously (17). Reaction times for all lanes of indi-
vidual blots are identical.
Several specific antibodies were used for studies to characterize the
location of separation of EDTAand saline-split skin. Mouse monoclo-
nal antibody to laminin (Calbiochem-Behring Corp., San Diego, CA)
was used at a dilution of 1:50 and the second antibody was fluores-
cein-conjugated goat antimouse IgG (IgG fraction, 13.5 mg/ml pro-
tein, 4.72 mg/g fluorescein to protein ratio; Cappel Laboratories) di-
luted 1:80 in PBS. Mouse monoclonal antibody to type IV collagen
(Chemicon International Corp., Inc., El Segundo, CA) was used at a
dilution of 1:200 in PBSand the second antibody was fluorescein-con-
jugated goat antimouse IgG diluted in PBS. Epidermolysis bullosa
acquisita serum was diluted 1:200 in PBS. This serum has been charac-
terized to demonstrate the classical reaction with the 290-kD type VII
collagen (10). The second antibody was goat antihuman IgG as above.
Mouse monoclonal antibody to fibronectin (Calbiochem-Behring
Corp.) was diluted 1:80 and used with fluoresceinated goat anti-mouse
antibody as above. All primary and secondary incubations were at
room temperature for 30 min. There were no significant differences in
location of antibody binding detected between I MNaCl and the
EDTAmethods using antisera to type IV collagen, fibronectin, elastin,
laminin, and type VII collagen (epidermolysis bullosa acquisita
serum).
Basement membrane zone immunoaffinity (Fig. 1). 25 cm2 of epi-
dermis separated by I MNaCl as noted above was diced into - 35
sections. This specimen was then incubated with 1 cm3 of the test
serum diluted 1:5 in PBSwith 10MIM PMSFfor 90 min. The specimen
was centrifuged at 3,000 g for 10 min, and the supernatant discarded.
The pellet was washed for 10 min three times in PBS, and then incu-
bated in 5 cm3 of 20 mMsodium citrate (pH 3.2) for 6 h at 37°C. After
centrifugation at 3,000 g for 10 min, the supernatant was decanted and
Table L Summary of Indirect Immunofluorescence and Western Blot Analyses of LABDPatient Sera
Serum Serum ZIA Nitrocellulose
IgA antibody titer* Antibody (1:10) Eluted antibody Eluted antibody
Split Split
Patient Monkey human Dermal Epidermal Dermal Epidermal human Dernal Epidermal
number esophagus skint extracti extract1 extractl extracti skint extract0 extract0
1 1:80 1:160 + + + + + + +
2 1:80 1:160 + + + + + + +
3 1:40 1:80 + + + + + + +
4 1:160 1:160 + + + ND ND ND ND
5 1:20 1:40 + - ND ND ND ND ND
6 1:10 1:20 + - ND ND ND ND ND
7 < 1:10 1:20 - - ND ND ND ND ND
8 < 1:8 1:20 - - ND ND ND ND ND
9 < 1:10 1:10 - - ND ND ND ND ND
10 < 1:10 < 1:10 - - ND ND ND ND ND
* Evaluation of serum IgA-class anti-basement membrane antibody titer by indirect immunofluorescence using monkey esophagus or 1 M
NaCi-split human skin as a substrate. * Staining of epidermal side of I MNaCI-split human skin by indirect immunofluorescence. § Western
blot using patient serum diluted 1:10, ZIA antibody, or nitrocellulose-eluted antibody to probe dermal and epidermal extract for reactivity with
the 97-kD band.
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Figure 1. Basement membrane zone immunoaffinity. Anti-basement membrane antibody is first absorbed from serum with isolated human
epidermis. The antibody is then eluted with citrate buffer, neutralized, dialyzed, Iyophilized, and resuspended in PBS. Controls on the effective-
ness of antibody absorption and elution are monitored with fluorescent microscopy.
neutralized to pH 7.3-7.5 with 2 MTris (pH 8.0) and BSAwas added
to a final concentration of 0.2 g/l00 cm3. The supernatant was dia-
lyzed overnight at 40C against distilled water. The sample was then
lyophilized and resuspended in 1 ml of PBS (final BSA concentration
1 g/100 cm3). Tween was then added to samples to be used for
Western blot to a final concentration of 0.05%.
Zone immunoaffinity (ZIA), performed as outlined above, was
evaluated by immunofluorescence at various stages. Fig. 2 A reveals
the indirect immunofluorescence of epidermis after the incubation
with LABD serum diluted 1:5. It shows deposition of IgA along the
basement membrane. Fig. 2 B is the indirect immunofluorescence of
human epidermis after incubation with normal serum diluted 1:5
showing no antibody deposition. Fig. 2 C reveals the epidermis pre-
viously incubated with LABD serum after washing with sodium ci-
trate, showing that antibody has been eluted from the epidermal sheet.
Fig. 2 D represents indirect immunofluorescence of the supernatant
obtained after elution of the antibody on normal human epidermal
substrate. This reveals an anti-basement membrane antibody present
at a titer of 1:20 in the eluate. The final protein concentration (exclud-
ing that attributed to the added BSA) of this eluate was < 5 'sg/ml,
indicating that the IgA-class anti-basement membrane antibody had
been significantly purified from its initial relative concentration in
serum.
Indirect immunofluorescence and Western blot of nitrocellulose
immunoaffinity-purified serum. Protein bands on nitrocellulose blots
of Laemmli gels were also used as immunoaffinity substrates to purify
antibodies directed against specific proteins in dermal extract as de-
scribed by Olmsted (18) and modified by Smith and Fisher (1 9). Ver-
tical lanes from both sides of the nitrocellulose imprint of the gel were
cut and immunochemically stained with sera to identify the bands of
interest. Horizontal strips of nitrocellulose containing the antigen of
interest, but not exposed to sera, were then cut and sera applied as 1:5
dilution in ATPBS for 2 h. After washing in ATPBS, the antibodies
were eluted in 600,ul 20 mMsodium citrate (pH 3.2), 0.05% Tween-20
for 3 min at 370C, and were immediately neutralized with 2.0 MTris
HCI (pH 7.5) to a final pH of 6.8.
Results
Indirect immunofluorescence. Indirect immunofluorescence
with LABDsera was performed with both monkey esophagus
and saline-split normal human skin as substrates and devel-
oped with both fluorescein-conjugated anti-IgA and anti-IgG.
No patient was found to have IgG-class anti-basement mem-
brane zone antibody titers on either tissue source. Screening
was done at a 1:10 dilution of serum. The IgA-class anti-base-
ment membrane antibodies are reviewed in Table I. 6 of 10
patients were found to have positive titers of at least 1:10
IgA-class antibody when monkey esophagus was used as a
tissue source. When saline-split skin was used as a tissue
source, 9 of 10 patients had antibody titers of at least 1:10. This
points out the superiority of saline-split skin as a tissue source
for indirect immunofluorescence as has been previously re-
ported in LABD (20). It should also be noted that all patients
showed at least a one-tube dilution greater titer when saline-
split skin was used as a tissue source. 14 normal human sera
were also tested in this manner and all were negative on indi-
rect immunofluorescence for both antibody classes. Patient 4
is the patient with cicatrizing conjunctivitis without skin le-
sions.
Specific fluorescence was noted only at the basement
membrane on the epidermal side of the split skin. No specific
dermal fluorescence was noted.
Western blots of epidermal extract. Western blots of epi-
dermal extracts were performed using skin separated by both
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Figure 2. Fluorescent microscopy control of basement membrane zone immunoaffinity procedure. (A) Staining of epidermal substrate with flu-
orescein-conjugated anti-IgA after initial incubation of LABDserum with sliced epidermal substrate demonstrating basement membrane depo-
sition of IgA. (B) Staining of epidermal substrate for IgA after incubation with normal serum fails to demonstrate basement membrane deposi-
tion of IgA. (C) Staining of epidermal substrate for IgA after elution of antibody with citrate buffer reveals no basement membrane IgA. (D) In-
direct immunofluorescence for IgA after incubating the citrate buffer eluted antibody with normal human epidermis demonstrates that the
eluate contains IgA-class anti-basement membrane antibody.
the 1 MNaCl technique and the 20 mMEDTA technique
outlined in Methods. Identical concentrations (1 10 ,ug/lane) of
epidermal extract obtained by both techniques were used for
Western blots, exposed to sera, and developed with avidin-
biotin-peroxidase complex. The Western blot of epidermal
extract obtained from 1 Msaline-split skin showed no consis-
tent antigen recognized by LABD sera, and the 97-kD band
subsequently discussed was not noted on these blots (data not
shown). The Western blots of epidermal extract obtained from
20 mMEDTAsplit skin exposed to LABDsera are shown in
Fig. 3. Lane I is the no-primary antibody control. Lanes 2-4
are patients with LABD (patients 1-3, Table I). Results on
patient 4 were similar (not shown). Lanes 5-7 were exposed to
the normal human sera. All lanes were stained with anti-IgA.
Several bands are recognized by sera from these patients with
LABD; a consistent band at 97 kD, as well as a variety of other
less consistent bands. The remainder of the LABDsera failed
to demonstrate the 97-kD band, but did show a number of less
consistent bands (not shown). Relatively high protein concen-
tration and low serum dilutions (1:10) were used to maximize
sensitivity. As a result, increased background is noted with
multiple bands in both test sera and normal sera. The positive
control lane was exposed to bullous pemphigoid serum and
developed with anti-IgG; it demonstrated a 240-kD band (not
shown).
Western blot of dermal extract. Fig. 4 demonstrates the
Western blots of dermal extract prepared from EDTA-split
skin exposed to sera and developed with avidin-biotin-perox-
idase complex. Lanes 1-6 are LABDsera (patients 1-6, Table
I) stained with anti-IgA. Lane 4 is serum from the patient with
cicatrizing conjunctivitis. Lanes 7-9 are normal sera. A band
in the 97-kD range is noted with LABDand cicatrizing con-
junctivitis patient sera. This becomes minimally detectable
when sera with lower antibody titers are used (lanes 5 and 6).
An additional dense 38-kD band is noted with the cicatrizing
conjunctivitis patient serum. The positive control lane was
exposed to epidermolysis bullosa acquisita serum developed
with anti-IgG and showed a characteristic 290-kD band as well
as some nonspecific staining (not shown). The protein con-
centration per lane in this blot is 1 12 pig/lane. It should be
noted that several additional bands can also be seen with nor-
mal human sera and large amounts of background with some
test sera. This is a result of using high concentrations of dermal
extract and low dilutions of test sera to maximize sensitivity
for detection of antigen antibody, thus allowing detection of
low titer or low avidity antibodies. The remainder of the sera
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200- strips are incubated.1 with patient serum at
I 1 6- l: lIo dilution and devel-oped with avidin-bio-
97- tin-peroxidase complex
and anti-IgA. Lane I is
a control with no pa-
6 6- tent serum added.
p
p p 4 ~~~~~ane 2-4 are incu-
bated with LABDpa-
tient sera. Lanes 5-7
I I are normal human sera.
Multiple bands are
identified by all sera. A
consistent band at 97
kD is identified by the LABDsera. Lower titer LABDsera failed to
identify the 97-kD band.
(patients 7-10 in Table I) failed to produce a band with dermal
extract (data not shown). Since these negative sera were the
ones with the lowest titer of antibody, it was felt that lack of
sensitivity was the likely reason for negative Western blots on
these specimens. Control sera from 10 patients with bullous
pemphigoid, 5 patients with pemphigus vulgaris, and 2 pa-
tients with epidermolysis bullosa acquisita were also evaluated
for antibodies of IgA class against the 97- and 112-kD band.
No reactivity of these sera was noted. We have previously
reported similar Western blot analysis of 63 patients with der-





matitis herpetiformis and 67 normal controls and neither the
97- or 1 12-kD band was consistently noted (21).
Western blot of EDTA-split skin epidermal extract stained
with ZIA-purified serum (Fig. 5). Lane I is the no-primary
antibody control. Lanes 2 and 3 are patients 1 and 2, Table I.
Lanes 4 and 5 are normal human sera. Lanes 2a-Sa are the
ZIA-purified specimens of respective sera.stained for IgA.
Lanes 2a and 3a show preservation of the 97-kD band after
affinity purification using human epidermis. The remaining
bands noted are related to nonspecific staining with the
secondary antibody (compare with no-primary antibody in
lane 1).
Western blot of dermal extract stained with ZIA-purified
serum (Fig. 6). The Western blot of the dermal extract stained
with ZIA-purified patient sera is shown in Fig. 6. Lanes 1-4 are
stained with the LABD sera, lane '4 is the serum from the
cicatrizing conjunctivitis patient, and lanes la-4a represent
the corresponding ZIA-purified sera all stained for IgA. Lanes
5-6 are normal human sera, and lane 5a-6a are ZIA purifica-
tion of normal human sera, stained for IgA. All patients dem-
onstrated persistence of the 97-kD band after the ZIA proce-
dure. The cicatrizing conjunctivitis patient demonstrated puri-
fication of both a 38- as well as a 97-kD band (lane 4a). The
ZIA-purified specimens eliminate the considerable back-
ground produced by using test sera at low titers and high tissue
extract concentrations. Dense bands that would seem to be of
great importance are eliminated after purification (lane la).
Indirect immunofluorescence and Western blot of nitrocel-
lulose immunoaffinity-purified serum. To further confirm that
the antigen detected on immunoblot corresponded with the
antigen detected using immunofluorescence, we used nitrocel-
lulose blots of dermal extract as an affinity substrate for anti-
body purification and probed epidermis with the resulting an-
tibody. Antibody was eluted from the 145-, 97-, and 55-kD
bands of dermal extract as described in Methods and reacted
with the basement membrane zone of EDTA-split epidermis
with indirect immunofluorescence (Fig. 7). This demonstrates
that the antibody reactive with the 97-kD, but not the 145- and
55-kD proteins, reacts with basement membrane zone.
1 2g 3 4 1 5
.uMm
Figure 4. Western blot of dermal extract from EDTA-separated skin.
Nitrocellulose strips are stained with patient serum at 1: 1O dilution
and developed with avidin-biotin-peroxidase complex and anti-IgA.
Lanes 1-6 are incubated with LABDpatient sera. Lane 4 is the cica-
trizing conjunctivitis patient serum, and lanes 7-9 are normal
human sera. A band is noted from LABDsera in the 97-kD region,
although all sera identify several other bands, some of which are
more dense. The cicatrizing conjunctivitis serum detects an addi-






Figure 5. Western blot
of epidermal extract
stained with ZIA-puri-
fied serum. All lanes are
stained with anti-IgA.
Lane 1 is a control with
no patient serum
added. Lanes 2 and 3
are incubated with
LABDpatient sera.








from LABDpatients shows purification of the 97-kD band. An addi-
tional band is seen at 80 kD which represents nonspecific binding of
the secondary antibody. The band at 30 kD absorbed from normal
serum (5a) is of uncertain significance.
816 J. J. Zone, T. B. Taylor, D. P. Kadunce, and L. J. Meyer







Figure 6. Western blot of dermal extract stained with ZIA-purified
serum. Lanes 1-4 are incubated with LABDsera. Lane 4 is the cica-
trizing conjunctivitis serum, and lanes 5 and 6 are normal human
sera. Lanes la-6a are corresponding ZIA-purified sera. Specific
staining of the 97-kD band in dermal extract is noted in lanes 2a, 3a,
and 4a. Additional binding to a 38-kD band is noted in the ZIA-pu-
rified cicatrizing conjunctivitis serum.
To identify possible cross-reactivity of antibodies eluted
from nitrocellulose with other antigens detected on dermal
extract, we used antibody eluted from specific bands of nitro-
cellulose to stain Western blots of dermal extracts. Fig. 8 is the
Western blot of dermal extract stained with whole LABD
serum from patient 1 (lane 1), antibody eluted from the 145-,
97-, and 55-kD bands (lanes 2, 3, and 4, respectively), and the
negative control with no primary antibody (lane 5). This dem-
onstrates that antibody eluted from the 145-kD band reacts
with this antigen, as well as a lesser antigen at 120 kD (lane 2).
Antibody eluted from the 97-kD band reacts with the 97-kD
band, as well as an antigen at 112 kD. This presumably repre-
sents a shared epitope between the 97- and 12-kD bands.
Lastly, antibody eluted from the 55-kD band reacts weakly
with that antigen, but apparently shares no epitopes with other
antigens. Nonspecific reactivity of the secondary antibody
with proteins in the 50-70-kD range is present in all lanes.
This reapplication of eluted antibody further confirms that the
antibodies under study were effectively eluted from nitrocellu-
lose under conditions that retained their immunoreactivity.
Similar results were noted with sera from patients 2 and 3
(Table I).
To establish that the 97-kD band reactive in epidermal
extract was the same antigen as that found in dermal extract,
we used antibody eluted from the 97-kD band on nitrocellu-
lose blots of dermal extract. This revealed specific staining of
only the 97-kD band on blots of epidermal extract and was
done with sera from both patients 1 and 2 (not shown).
Weconclude from the nitrocellulose elution studies that
the antibody reactive with the 97-kD band on dermal and
epidermal extract is the antibody in serum that is responsible
for the basement membrane zone staining seen on indirect
immunofluorescence of serum.
Discussion
LABD is an uncommon blistering disease of the skin in which
a vesicle forms in the basement membrane zone in association
Figure 7. Indirect immunofluorescence of antibody eluted from ni-
trocellulose blots of dermal extract. Staining of epidermal substrate
with fluorescein-conjugated anti-IgA after incubation with antibody
eluted from various areas on nitrocellulose. (A) Antibody eluted
from the 145-kD area does not bind basement membrane. (B) Anti-
body eluted from the 97-kD area binds basement membrane. (C)
Antibody eluted from the 55-kD area does not bind basement mem-
brane.
with the linear deposition of IgA in perilesional skin (1, 4, 7).
Inasmuch as IgA and complement are found along the base-
ment membrane and because some patients have circulating
IgA-class antibodies to basement membrane in their serum, it
is likely that immunologic mechanisms are operative in the
pathogenesis of individual blisters. Someauthors have charac-
terized LABD as a subclass of dermatitis herpetiformis, but
numerous dissimilarities do not support this concept. Classical
dermatitis herpetiformis is characterized by involvement of
extensor surfaces with scattered papulovesicles, a > 85% inci-
dence of the HLA B8 DR3 haplotype, the presence of gluten-
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2 3 4 5 Figure 8. Western blot of antibody
eluted from nitrocellulose blots of
dermal extract. Nitrocellulose strips
are developed with avidin-biotin-per-
200C oxidase complex and anti-IgA. Lane II is incubated with LABDserum di-
luted 1:10. Lane 2 is incubated with
11 6-.. | antibody eluted from the 145-kD area
1f and demonstrates preservation of im-
munoreactivity of that antibody with
some apparent cross-reactivity with
6 6- the 1 12-kD band. Lane 3 is incubated
with 97-kD eluate and reactivity with
both the 97- and 1 12-kD bands is
noted. Lane 4 is incubated with the
55-kD eluate and shows minimal re-
activity. Lane S is the control that
omits the primary antibody and
shows nonspecific staining.
sensitive enteropathy in > 90% of patients, and granular depo-
sition of IgA in the basement membrane zone frequently fo-
cused in dermal papillary tips when perilesional, clinically
normal-appearing skin is biopsied. LABDpatients in contrast
have a vesiculobullous disease with variable cutaneous distri-
bution, a 30-40% incidence of the HLA B8 DR3 haplotype, a
rare association with gluten-sensitive enteropathy, and linear
deposition of IgA along the basement membrane (1, 3, 4).
Immunoelectron microscopy of LABD reveals deposition of
IgA antibody in the lamina lucida of the basement membrane
zone in some patients, and subbasal lamina deposition in
others (5, 6, 8). This contrasts sharply with the immunological
findings in granular IgA disease where the IgA is bound to
fibrillar components of elastic fibers in the papillary dermis (5,
6). Therefore, despite the likelihood that both dermatitis her-
petiformis and LABD are mediated by an IgA-class immune
response, their putative antigens are likely different.
Similar assumptions have been made for other blistering
diseases, including bullous pemphigoid and epidermolysis
bullosa acquisita, which are characterized by IgG antibody
deposition along the basement membrane. Sera from most
patients with bullous pemphigoid contain an antibody to a
240-kD protein within the lamina lucida (1 1, 12), and sera
from epidermolysis bullosa acquisita patients contain an anti-
body to type VII collagen present in the subbasal lamina (9,
10). Since both bullous pemphigoid and LABDmay demon-
strate deposition of immunoglobulin in the lamina lucida, it
seemed possible that LABD simply represented an IgA-class
response to the bullous pemphigoid antigen. Understanding of
this relationship has been impeded by the presence of rela-
tively low titer autoantibodies in LABD. Wehave evaluated
multiple LABDsera for IgA-antibody reactivity with the base-
ment membrane zone on indirect immunofluorescence and
Western blot of epidermal and dermal extracts. We further
purified the LABD autoantibody using the new technique of
basement membrane zone immunoaffinity, as well as elution
from nitrocellulose of IgA-class antibody that binds cutaneous
basement membrane. These studies show that the LABDanti-
gen is distinct from the described major bullous pemphigoid
antigen.
6 of 10 serum samples from patients with LABDcontained
IgA-class autoantibodies that bound to the basement mem-
brane of monkey esophagus, a commonsubstrate for detection
of basement membrane autoantibodies. When indirect immu-
nofluorescence was performed on our sera using 1 Msaline-
split skin as a substrate, 9 of 10 LABD sera demonstrated
circulating IgA-class anti-basement membrane antibody,
pointing out the superiority of saline-split skin as a substrate
for detection of low titer basement membrane zone antibodies.
1 MNaCl has been shown to separate the basement membrane
zone through the lamina lucida leaving the bullous pemphi-
goid antigen on the epidermal side and components of the
lamina densa and subbasal lamina on the dermal side (22, 23).
EDTAalso produces epidermal separation and we have shown
that 20 mMEDTAproduces a separation similar to 1 MNaCl
(24). Consequently, antibody that reacts to the epidermal por-
tion of split human skin is binding at the lamina lucida or
above. All nine of our positive sera showed binding to the
epidermal portion of the saline-split skin, indicating that the
IgA was directed toward an antigen within or above the lamina
lucida as is the case with IgG in bullous pemphigoid. This was
confirmed in two patient biopsies by direct immunoelectron
microscopy. Therefore, it would appear that none of our pa-
tients had the subbasal lamina type of IgA deposition de-
scribed by others. LABDis an uncommondisease and we have
no further explanation for the paucity of such cases in our
series.
We initially evaluated high concentrations of epidermal
and dermal extracts of saline-split skin for binding of LABD
IgA-class antibodies. Wewere unable to identify any consis-
tent pattern on epidermal extract but were able to identify a
consistent band at 97 kD in dermal extract using the four
highest titer sera. Because these IgA-class antibodies were
found to react with the epidermal portion of saline-split skin
on indirect immunofluorescence, we would have expected the
sera to react with epidermal extract rather than dermal extract.
When EDTA-split skin was used as a source for epidermal
extract, we were able to identify the 97-kD band within epi-
dermal extract. The amount of antigen, however, appears to be
greater in dermal extract under all conditions, for with similar
concentrations of extract, the 97-kD protein band is more in-
tense on dermal extract and was recognized by three additional
sera. It seems likely that the relatively harsh conditions of 1 M
NaCl separation in combination with the extraction procedure
quantitatively decreased the immunoreactivity of the putative
antigen on Western blot while preserving some immunoreac-
tivity on immunofluorescence. EDTA is a protease inhibitor
as well as an agent that produces basement membrane zone
separation and is likely to minimize protein denaturation.
Wefelt it was essential to show that the band demonstrated
by Western blot on dermal extract and epidermal extract was
actually being produced by the IgA-class antibody, which
bound to the epidermal portion of split skin on indirect immu-
nofluorescence. For this purpose, we initially devised the base-
ment membrane zone immunoaffinity techniques. This tech-
nique allowed binding of the anti-basement membrane anti-
body to epidermal portions of the basement membrane with
subsequent elution. These eluates were found to have titers of
IgA-class anti-basement membrane zone antibody of 1:10 or
greater despite the fact that protein concentrations were < 5 ig
in the eluate. This indicates elimination of the vast majority of
nonspecific protein and presumably leaves only antibodies to
basement membrane zone proteins present in the lamina lu-
cida or above. This series of experiments showed that the base-
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ment membrane zone immunoaffinity-purified antibody
reacted only with the 97-kD antigen extracted from both epi-
dermis and dermis. Wewere unable to detect discrete binding
of LABDantibody to the dermal component of split skin using
indirect immunofluorescence with patient serum or various
affinity-purified eluates. It is our opinion that the antigen is
likely produced by fibroblasts in the dermis and secreted in a
soluble form with subsequent binding to the lamina lucida.
Large amounts of soluble antigen could then be extracted from
dermis, but not recognized as discrete fluorescence. Extraction
of the epidermis and the basement membrane would then
yield only small amounts of antigen which were minimally
detectable by our low titer antibody. This would explain the
small amount of the LABDantigen in epidermal extract and
its presence in dermal extract. In contrast, the bullous pem-
phigoid antibody has been regularly extracted from the epi-
dermal portion of the split skin (12, 13). However this antigen
has also been shown to be produced by keratinocytes which are
present in the tissue being extracted. It seems possible that the
relatively harsh extraction conditions could release intracellu-
lar keratinocyte proteins which might well be responsible for
the majority of antigens detected by bullous pemphigoid
serum on Western blot rather than antigen bound at the base-
ment membrane.
Because we used low dilutions of serum antibody and high
concentrations of extract, several bands that we believed to be
nonspecific were seen on Western blot of both the epidermal
and dermal extract with LABDsera. Immunoaffinity purifica-
tion of antibody with epidermis allowed elimination of such
background and easy identification of bands by eliminating
large quantities of nonspecific protein. Wethen sought to con-
firm the specificity of the 97-kD antigen by a second line of
investigation. Weused nitrocellulose blots as an affinity sub-
strate for antibody purification and then probed epidermis and
dermis with the resulting antibody. This showed that the IgA-
class antibody eluted from the 97-kD antigen reacted with
basement membrane, whereas antibody eluted from other
bands on the blot failed to react with basement membrane as
evaluated by immunofluorescence. The efficacy of elution
from nitrocellulose and the maintenance of immunoreactivity
of these solutions was confirmed by Western blots and demon-
strated what we interpret to be shared epitopes in some cases.
The antigen identified by our LABD sera appears to be
distinct from the antigen identified by Stanley and co-workers
(12) because this antigen has been described as varying in size
between 220 and 240 kD and the antigen identified by LABD
sera is 97 kD. Staining of our extracts with bullous pemphigoid
and epidermolysis bullosa acquisita sera showed that classical
240-kD bullous pemphigoid band on epidermal extract and
290-kD epidermolysis bullosa acquisita band on dermal ex-
tract, indicating that these antigens were preserved by our ex-
traction procedures, but not recognized by our LABD sera.
Therefore, it seems reasonable to conclude that the LABD
antigen in lamina lucida-type LABD is distinct from the clas-
sical 240-kD bullous pemphigoid band, and LABDdoes not
simply represent an IgA-class immune response to the bullous
pemphigoid antigen. Labib and co-workers have described oc-
casional bullous pemphigoid sera that recognize a 97-kD pro-
tein (13). Whether this is the same antigen recognized by our
LABDsera will require further investigation.
Interestingly, our single cicatrizing conjunctivitis without
cutaneous lesions showed an additional band present in both
epidermal and dermal extract which was 38 kD in size. This
protein was still specific after ZIA. It is impossible to tell what
role this antigen might be playing in the differential expression
of disease. Wepresent these results for interest and hope that
these data will be expanded by the experience of others in this
rare disease.
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